3rd Quarter - Report

ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General reimbursement issues

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY New Counsel, Senate HELP and Sen. Chuck Hagel
RICHARD CHARLES WHITE New Legislative Coordinator, Sen. John Charles

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

The Federal, Food, Drug and Cosmetic Act The Prescription Drug User Fee Act (PDUFA) Generating Antibiotic Incentives Now (GAIN) Act Patient Protection and Affordable Care Act FDA Safety & Innovation Act

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY New Counsel, Senate HELP and Sen. Chuck Hagel
RICHARD CHARLES WHITE New Legislative Coordinator, Sen. John Charles

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.